Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Testicular cancer Stories

2007-08-16 06:16:43

By Bahrami, Armita Ro, Jae Y; Ayala, Alberto G Context.-More than 90% of testicular neoplasms originate from germ cells. Testicular germ cell tumors (GCTs) are a heterogeneous group of neoplasms with diverse histopathology and clinical behavior. Objective.-To help the readers distinguish various subtypes of GCTs, to highlight the clinical manifestations and pathologic features of these tumors, and to review several newly developed immunohistochemical markers for GCTs. Data Sources.-Review...

2007-03-23 06:00:11

By Ouellette, James R; Harboe-Schmidt, Jens Erik; Luthringer, Daniel; Brackert, Sandra; Silberman, Allan W Metastatic lesions to the testicle are uncommon. The authors report a testicular mass as the initial manifestation of distant metastasis from colorectal cancer. This case describes a 51-year- old white man who presented with an enlarged right testicle 9 months after undergoing a right hemicolectomy for a stage IIIC colon adenocarcinoma. The diagnostic and management strategy is...

2006-02-15 15:15:00

NEW YORK (Reuters Health) - Survivors of testicular cancer have a moderately increased risk of heart attack at young ages, according to Dutch researchers. Testicular cancer is the most common cancer for men between 20 and 35 years of age. The increased heart attack risk seen in the current study applied to men with nonseminomatous testicular cancer, a common type that is very resistant to radiation therapy and can spread to the lungs, liver, bones, or brain. Dr. Flora E. van Leeuwen, of the...

2005-11-21 13:29:42

By Anne Harding NEW YORK (Reuters Health) - Men who are undergoing treatment for infertility are 20 times more likely than men in the general population to be diagnosed with testicular cancer, a new study shows. The finding underscores the importance of urological screening for any man with infertility, Dr. Marc Goldstein said, especially because this evaluation is often not a part of infertility treatment. Male infertility is frequently handled by reproductive endocrinologists, and...

2005-11-01 16:58:06

NEW YORK (Reuters Health) - After treatment for testicular cancer, about 71 percent of men achieve fatherhood, new research indicates. However, the type of treatment has a strong impact on the paternity rate. The findings, which appear in the Journal of the National Cancer Institute, are based on a study of 554 long-term survivors of testicular cancer who attempted to become fathers following treatment. Dr. Marianne Brydoy, from Haukeland University Hospital in Bergen, Norway, and...

7d598190af3f71d11e87c0e629549c551
2005-09-21 17:00:00

NEW YORK -- Men like cyclist Lance Armstrong and comedian Tom Green who survived testicular cancer are at increased risk of developing other types of cancer for at least 35 years after being diagnosed with the original disease, a new analysis shows. The study also showed for the first time a greater risk of malignant mesothelioma, a cancer affecting the lining of the lungs, and esophagus cancer among testicular cancer survivors, likely due to the outdated practice of treating these patients...

2005-08-25 11:46:11

By Amy Norton NEW YORK (Reuters Health) - Sperm banking may not only preserve young cancer patients' ability to have children, but their emotional well-being as well, according to Japanese researchers. They found that among 51 young men who banked their sperm before undergoing chemotherapy, 80 percent said that the move helped them in the "emotional battle against cancer." Even those who were unsure whether they wanted to have children in the future gained some peace of mind from...

2005-08-23 16:25:00

NEW YORK -- Pregnant women's weight is apparently associated with the subsequent risk of testicular cancer in male offspring once they become adults, according to a Scandinavian study. Higher maternal weight leads to higher levels of estrogens, which can be transferred from mother to fetus via the placenta. "Increased fetal exposure to estrogen during the first trimester of pregnancy has been proposed as a risk factor for the development of testicular cancer later in life," Dr. Tom...

2005-08-23 08:53:04

By Patrick Vignal PARIS (Reuters) - Seven-times Tour de France winner Lance Armstrong has denied ever taking performance-enhancing drugs following a report in French newspaper L'Equipe that he had used the blood-boosting drug EPO. Tour de France executive director Jean-Marie Leblanc said he felt let down by Armstrong after L'Equipe alleged the American had taken the banned drug in 1999, the year he first won the world's greatest cycle race. Armstrong, who recovered from testicular...